Research & Clinical Trials
Latest T-Cell Clinical Trial Opens for Mesothelioma Patients
- by Tim Povtak
- Research & Clinical Trials
- Oct 8, 2020
Memorial Sloan Kettering Cancer Center in New York City has begun recruiting patients with pleural mesothelioma for its latest — and potentially most promising — clinical trial involving T-cell…
Read More
Gene Therapy Clinical Trial for Mesothelioma Moving Forward
- by Tim Povtak
- Research & Clinical Trials
- Sep 23, 2020
A much-anticipated, phase III clinical trial studying the use of gene therapy to combat pleural mesothelioma cancer has made a promising start. Interest is growing in what many believe…
Read More
Mesothelioma Trial to Test Cancer Vaccine with Immunotherapy
- by Tim Povtak
- Research & Clinical Trials
- Sep 14, 2020
A research team at Oslo University Hospital in Norway has opened a mesothelioma clinical trial using the novel UV1 cancer vaccine alongside a promising immunotherapy combination. UV1 is a…
Read More
New Lung Cancer Trial Could Benefit Mesothelioma Patients
- by Sean Marchese
- Research & Clinical Trials
- Aug 19, 2020
Pharmaceutical giant Merck has teamed up with Novocure to test its cornerstone immunotherapy, pembrolizumab (Keytruda), alongside Tumor Treating Fields. The new phase II clinical research trial is focusing on…
Read More
Immunotherapy Combination Extends Mesothelioma Survival
- by Tim Povtak
- Research & Clinical Trials
- Aug 11, 2020
Standard-of-care treatment for unresectable pleural mesothelioma cancer could be changing soon, sparked by a recently completed international study of a novel immunotherapy combination. Patients in the randomized mesothelioma…
Read More
Mesothelioma Clinical Trials Resume After COVID-19 Disruption
- by Sean Marchese
- Research & Clinical Trials
- Aug 10, 2020
When the COVID-19 pandemic struck earlier this year, clinical trials at medical centers around the world slowed enrollment or placed trial activities on hold. As businesses begin to reopen…
Read More
Mesothelioma T-Cell Therapy Shows Early Effectiveness in Trial
- by Tim Povtak
- Research & Clinical Trials
- Aug 4, 2020
A mesothelioma clinical trial involving genetically modified T cells has opened to considerable acclaim, shrinking tumors in the first five patients who were treated. The phase I portion of the…
Read More
Study Shows Peritoneal Mesothelioma Surgery Underutilized
- by Tim Povtak
- Research & Clinical Trials
- Jul 28, 2020
The continued underutilization of aggressive surgery for peritoneal mesothelioma is shortening survival time dramatically for patients who could qualify for, and benefit from, the highly effective procedure. Only a…
Read More
Merck, Targovax Team Up for New Mesothelioma Clinical Trial
- by Tim Povtak
- Research & Clinical Trials
- Jul 22, 2020
Standard-of-care treatment for malignant mesothelioma could change significantly, depending upon the results of an upcoming clinical trial of two immunotherapy agents used in combination with chemotherapy. The mesothelioma…
Read More
NCI Studying New Mesothelioma Immunotherapy Combination
- by Tim Povtak
- Research & Clinical Trials
- Jul 8, 2020
Patients with mesothelioma are being recruited by the National Cancer Institute for a phase II clinical trial using a novel immunotoxin prior to pembrolizumab, a combination that has…
Read More
